![]()
|
|
||||||||
J. Biol. Chem., Vol. 276, Issue 34, 31825-31830, August 24, 2001
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
-Oxidation and Peroxisome Proliferation by Regulating
POX1 and PEX11*
§,
,
,
,
, and
**
From the
Institut für Biochemie und Molekulare
Zellbiologie der Universität Wien and Ludwig
Boltzmann-Forschungsstelle für Biochemie, Vienna Biocenter, Dr
Bohrgasse 9, A-1030 Vienna, Austria, the ¶ Biocenter Oulu,
Department of Biochemistry, University of Oulu, FIN-90570 Oulu,
Finland, and the
FU Berlin, FB Biologie, Chemie, Pharmazie,
Thielallee 63, D-14195 Berlin, Germany
Received for publication, June 27, 2001
| |
ABSTRACT |
|---|
|
|
|---|
Saccharomyces cerevisiae
Adr1p is essential for fatty acid degradation and peroxisome
proliferation. Here, the role of Adr1p was examined with respect to the
transcriptional regulation of the Pip2p-Oaf1p dependent
genes POX1 and PEX11. POX1
encodes the rate-limiting enzyme of peroxisomal Defective peroxisomal In S. cerevisiae, peroxisomes represent the exclusive site
for fatty acid The dual response to oleic acid is also severely impaired in
adr1 With respect to the In the present study, the role of Adr1p was examined with respect to
the regulation of POX1 and PEX11. We also studied
the significance of the close proximity between OREs and UAS1s that appears in these as well as in several other genes involved in fatty
acid Strains, Plasmids, and Oligonucleotides--
Escherichia
coli strain DH10B was used for all plasmid amplifications and
isolations as well as for producing recombinant Adr1p-LacZ from plasmid
pQC-A229Z (20). The construction of strains MF14 and
MF14adr1 Media and Growth Conditions--
For RNA isolations, logarithmic
cultures of cells were shifted to yeast extract/peptone medium (1% w/v
yeast extract/2% w/v meat peptone) containing the indicated carbon
sources and grown for a further 16 h (8). For
Immunoblotting--
Whole-cell extracts were prepared according
to the published protocol (25). Monoclonal anti-yeast
3-phosphoglycerate kinase (Pgk1p) antibodies were obtained from
Molecular Probes (Eugene, OR). Antibodies against Fox3p (26) or Pex11p
(18) have been described previously. The antibody against Cta1p was a
gift from the laboratory of Dr. H. F. Tabak, and that against
Pox1p was a gift from the laboratory of Dr. W.-H. Kunau. Immunoreactive complexes were visualized using anti-rabbit or anti-mouse IgG-coupled horseradish peroxidase in combination with the ECLTM system
from Amersham Pharmacia Biotech.
Enzyme Assays--
Miscellaneous--
The following procedures were performed
according to published methods: nucleic acid manipulations,
formaldehyde gel electrophoresis, blotting and hybridization (30),
yeast RNA preparation for Northern analysis (31), determination of
protein concentration (32), and electrophoresis (33). The use of
POX1, PEX11, POT1/FOX3, CTA1, and ACT1 as probes in the Northern blot has
been reported previously (8). Protein-DNA binding experiments were
performed according to a published protocol (8). Fragments containing UAS1CTA1 or POT1/FOX3 ORE were isolated from the
plasmids pLW81 (16) and pSKFOX3ORE (34), respectively. DNA fragment
isolations were performed using QIAEX II (Qiagen, Valencia, CA).
Expression of Pox1p and Pex11p Depends on Adr1p--
The promoters
of both POX1 and PEX11 contain potential UAS1s.
However, unlike the canonical UAS1 in the POX1 promoter
(12), the promoter of PEX11 contains two UAS1-like variants.
One occurs at position
To determine whether Adr1p is important for transcribing
POX1 or PEX11, a Northern blot was used to study
transcription in cells grown under various carbon source conditions.
RNA was extracted from wild-type and adr1
To substantiate the apparent requirement for Adr1p to express Pox1p and
Pex11p, immunoblotting was performed on soluble protein extracts from
wild-type, adr1 UAS1POX1 Interacts with Adr1p--
We then tested
whether the canonical UAS1POX1 might represent a binding
target for Adr1p. As for PEX11, it resembled GUT1 (36) in that its promoter contains a potential Adr1p element with two
half-sites arranged as a direct repeat. In addition, the
PEX11 promoter also has a potential UAS1/ORE overlap similar to that in SPS19 (16) (Fig. 2,
A and B). Although the issue of whether Adr1p
directly regulates PEX11 remains open, the binding properties of these two classes of element arrangements,
i.e. linear or ORE overlapping, have been investigated
previously. On the other hand, the POX1 promoter contains a
novel arrangement that consists of a potential UAS1POX1,
within which is nested the entire POX1 ORE (Fig.
2C). To study the protein-binding properties of the two
superimposed elements in POX1, an electrophoretic mobility shift assay (EMSA) was performed using competitor DNA fragments generated from annealed oligonucleotide pairs. The results
demonstrated that the addition of soluble protein extracts from
wild-type cells grown on oleic acid to labeled POT1/FOX3 ORE
gave rise to a Pip2p-Oaf1p complex (8, 9) that was missing from the
extract derived from similarly grown
pip2
To resolve the two overlapping promoter elements with respect to their
ability to bind Adr1p, a competition EMSA was performed on
labeled UAS1CTA1 using a recombinant Adr1p-LacZ fusion
protein (20). The results demonstrated that the Adr1p-specific complex (16, 20) formed (Fig. 2D, lane 10) could be
competed by adding excess UAS1POX1 but not POX1
ORE (lanes 14 and 15). The addition of excess
UAS1CTA1 or UAS1SPS19, but not SPS19
ORE, gave a similar pattern of competition (lanes 11-13).
Hence, it was reasoned that despite the ORE incorporated into it, the
canonical UAS1POX1 represented a bona fide Adr1p
element. The results also revealed an apparent intensification of the
Adr1p signal in lanes containing SPS19 ORE or
POX1 ORE competitor DNA (lanes 13 and
15) compared with the situation without competition
(lane 10). However, this signal enhancement probably did not
indicate an ORE-specific transactivation of UAS1 binding, because
previous EMSAs (16) have shown that the addition of an ORE-less
competitor DNA (BUFPAL) (34) also had a similar effect.
A Combination of ORE and UAS1 Is Required for Full Transcriptional
Induction of CTA1--
The prevalence of closely associated OREs and
UAS1s among genes involved in peroxisomal processes has been reported
previously (16). This raised the issue of whether the two elements
cooperate to act as a transcriptional enhancer. The promoter elements
in POX1 and PEX11 were deemed inappropriate for
examining this potential cooperation, because in the former promoter
the superimposition of the two elements is unique to this gene, whereas
in the promoter of the latter gene the sequence overlapping the ORE is
not a canonical UAS1.
Instead, we used the CTA1 promoter (Fig.
3A) to study the possible
interaction between the two elements because (i) it contains a UAS1/ORE
overlap, (ii) mutating either PIP2 or ADR1 did
not lead to a complete loss of induced expression (Fig. 1B),
which should facilitate analysis of the combined effect of both
factors, and (iii) activities of reporter genes based on dissected
CTA1 promoter fragments can be measured simultaneously with
those of native catalase A using a convenient assay.
UAS1CTA1 resembles the cognate sequence in the promoter of
ADH2 (Fig. 3B) in that both elements contain a
second half-site at their 5' end (Fig. 3, A and
B, underlined). The minimal sequences in
UAS1CTA1 and UAS1ADH2 sufficient to form
protein-DNA complexes with Adr1p are indicated (Fig. 3, A
and B, brackets above sequences). By inserting the minimal UAS1CTA1, the isolated CTA1 ORE, or
a stretch of DNA containing both elements (Fig. 3C) into a
basal CYC1-lacZ reporter gene, it was possible to examine
these promoter regions either as dissected or combined elements.
Oleic acid-induced yeast cells harboring a single copy of each of these
integrative constructs were assayed for
On ethanol, Adr1p predominated over Pip2p-Oaf1p in regulating
CTA1, as judged by both types of enzyme activities (Table
I). This was in agreement with current understanding of Pip2p-Oaf1p function that stipulates it is inactive in the absence of fatty acids
(37). However, on oleic acid CTA1 ORE and
UAS1CTA1 acted in synergy to enhance CTA1
expression. This indicated that a close association of these two
elements in other dually regulated genes such as POX1 and
potentially also in PEX11 might also act synergistically.
Yeast cells devoid of Adr1p fail to utilize oleic acid as a
sole carbon source or to expand their peroxisomal compartment (5). In
the present study, the probable cause for this dual phenotype was
revealed to be a defect in the expression of Pox1p and Pex11p. Although
both FOX2 (encoding peroxisomal multifunctional enzyme type
2) (38) and POT1/FOX3 (encoding peroxisomal thiolase) (39,
40) have been shown previously to be influenced by Adr1p (5, 14), it
was hitherto not clear to what extent the carbon flux through
Adr1p control was also demonstrated for PEX11, as determined
by transcriptional analysis and immunoblotting. A direct role for Adr1p
in regulating PEX11 remains to be demonstrated, because in
contrast to POX1, the PEX11 promoter does not
contain a canonical UAS1. Nevertheless, because of the occurrence of an
ORE-overlapping sequence in the PEX11 promoter with only one
mismatch to the UAS1 consensus, it is at least plausible that Adr1p
might bind the PEX11 promoter. The possibility that the
tandem array of UAS1 half-sites in the vicinity of the PEX11
ATG start site (at position Mutant cells lacking Pex11p or Pox1p resemble each other in that
their peroxisomes appear enlarged, albeit reduced in number (4), and it
has been suggested that this shared phenotype is caused by the absence
of a putative metabolic signal generated via medium-chain fatty acid
Using a basal CYC1-lacZ reporter gene, the
significance of overlapping UAS1/ORE elements prevalent among oleic
acid-inducible genes was addressed. This revealed that the combined
potential for transcriptional activation of the isolated
CTA1 ORE and UAS1CTA1 was about 2.5-fold less
than that conferred on the basal promoter by the arrangement found in
the native promoter. This indicated synergy between the respective
Pip2p-Oaf1p and Adr1p transcription factors. The argument for synergy
was further supported by the observation that expression of the ORE
reporter (pMF22) in the adr1 This postulate must take into account dual occupancy of the two
transcription factors in such promoters where ORE and UAS1 overlap.
Pip2p-Oaf1p can bind and weakly activate single half-sites within OREs
(21, 35). Similarly, Adr1p can bind each of the two half-sites in UAS1
independently of each other (12). Hence, it is possible that not all of
the contact sites within the corresponding palindromes are occupied
simultaneously by Pip2p-Oaf1p and Adr1p in such overlapping element arrangements.
Finally, analysis of the PIP2 promoter revealed a
sequence overlapping the PIP2 ORE with some semblance to
UAS1, at position
-oxidation, acyl-CoA
oxidase. The POX1 promoter was shown to contain a canonical
Adr1p element (UAS1), within which the oleate response element (ORE)
was nested. PEX11 codes for a peroxin that is critical
for normal peroxisome proliferation, and its promoter was shown
similarly to contain a UAS1-like element overlapping the ORE. Northern
analysis demonstrated that transcriptional up-regulation of both
POX1 and PEX11 was abolished in
adr1
mutant cells, and immunoblotting confirmed that the
abundance of their gene products was dramatically reduced. Studies of an overlapping ORE/UAS1 arrangement in the CTA1
promoter revealed synergy between these elements. We conclude
that overlapping ORE and UAS1 elements in conjunction with their
binding factors Pip2p-Oaf1p and Adr1p coordinate the carbon flux
through
-oxidation with peroxisome proliferation.
![]()
INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
-oxidation has serious implications to
human patients, with death occurring often within the first year of
life (1, 2). The largest group of peroxisomal diseases consists of
aberrations in
-oxidation caused by a single defective enzyme (1).
Defects resulting in a drop in the carbon flux through
-oxidation
additionally impede the scheduled expansion of the peroxisomal
compartment both in human cells (3) and in those of the yeast
Saccharomyces cerevisiae (4). This study is concerned with
the molecular basis for the defects in
-oxidation and peroxisome
proliferation in yeast cells devoid of Adr1p (5).
-oxidation (6). Supplying S. cerevisiae
cells with oleic acid as a sole carbon source causes them to induce the
transcription of genes involved in fatty acid
-oxidation by about
10-fold (7, 8) and also to increase dramatically the number and size of
their peroxisomes (7). This dual response to oleic acid is mediated by
the Pip2p-Oaf1p transcription factor, which binds to a promoter element
termed ORE1 in target genes
(8, 9). Cells devoid of this transcription factor fail to degrade oleic
acid or expand their peroxisomal compartment (8, 9).
mutant cells, which similarly are unable to break
down oleic acid or proliferate their peroxisomes (5, 10). The Adr1p
transcription factor has been identified previously as a regulator
of the alcohol dehydrogenase gene ADH2 (11). Adr1p binds to
the consensus sequence
C(T/C)CC(A/G)(A/T/G)N4-36 (T/A/C)(T/C)GG(A/G)G, termed
UAS1 (12). Adr1p is also known to regulate the transcription of
the gene for peroxisomal catalase A by binding directly to
UAS1CTA1 (5); however, the influence of Adr1p on the
transcription of genes encoding peroxisomal
-oxidation enzymes such as Fox2p and Pot1p/Fox3p was reported to be less pronounced and possibly indirect (13, 14). Interest in the role of
Adr1p in peroxisome function was regained recently by the
finding that Adr1p tightly regulates SPS19 encoding
peroxisomal 2,4-dienoyl-CoA reductase by binding to
UAS1SPS19 (15, 16). However, because neither
CTA1 nor SPS19 are essential for growth on oleic
acid, the precise role of Adr1p in regulating either the carbon flux
through the
-oxidation spiral or peroxisome proliferation is still not understood fully.
-oxidation phenotype of
adr1
mutant cells, a canonical UAS1
(CTCCGAN36TTGGGG) occurs at position
247 upstream of the
ATG start site of POX1 (12), the product of which, acyl-CoA
oxidase, represents the first and rate-limiting step of the
-oxidation spiral (17). Hence, if POX1 were to
turn out to be regulated by Adr1p, it could explain why the
adr1
mutant strain fails to degrade oleic acid. As for
the reduced size and number of peroxisomes in the adr1
mutant (10), a possible clue for this might lie in the similarity to
the situation in pip2
and oaf1
strains (8,
9). These latter two mutants have smaller and fewer peroxisomes because they fail to transcribe properly the Pip2p-Oaf1p dependent gene PEX11 (8). Pex11p is vital for proper proliferation of an
otherwise readily discernible peroxisomal compartment (18, 19) and is also critical for Faa2p-dependent activation of
medium-chain fatty acids prior to
-oxidation (4).
According to the yeast data bases, the PEX11 promoter
contains UAS1-like sequences; therefore, should the gene be
demonstrated to depend on Adr1p for its transcription, this could shed
additional light on the reason for the peroxisome-proliferation phenotype of the adr1
mutant.
-oxidation. The results are discussed in terms of processes contributing to peroxisome proliferation.
![]()
EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
(21) derived from GA1-8C (MATa leu2 ura3-52 his3 trp1 ctt1-1 gal2)
(5) or BJ1991pip2
, BJ1991oaf1
,
BJ1991pip2
oaf1
(8, 22), and
BJ1991pox1
(23) derived from BJ1991 (MAT
leu2 ura3-52 trp1 pep4-3
prb1-1122 gal2) (24) has been described. Strain
BJ1991adr1
was a gift from the laboratory of Dr. H. F. Tabak. The deletion of the PIP2 gene in strains MF14,
MF6, MF17, and MF22 or in the corresponding adr1
mutant
strains was performed as described (8). Construction of plasmids pMF6,
pMF14, pMF17, and pMF22 have been described previously (21).
Oligonucleotides representing UAS1SPS19 (16), SPS19 ORE (15), UAS1CTA1 (16),
POT1/FOX3 ORE (34), and POX1/FOX1 ORE (22) are as
described. UAS1POX1 was generated by annealing the
oligonucleotide pair POX1ADR1-F
(5'-TCGACACTCCGAAGCGAAAGGAATTCGGTCATTAGCGGCTAATAGCCGTTGGGGTG-3') and
POX1ADR1-R
(5'-TCGACACCCCAACGGCTATTAGCCGCTAATGACCGAATTCCTTTCGCTTCGGAGTG-3').
-galactosidase measurements, cells were induced in oleic
acid medium as described (16). For immunoblotting, cells were grown in
yeast extract/peptone medium containing 2% (w/v)
D-glucose, shifted to yeast extract/peptone medium
containing either 4% (w/v) D-glucose, 2.5% (v/v) ethanol,
or 0.2% (w/v) oleic acid and 0.02% (w/v) Tween 80 (adjusted to pH 7.0 with NaOH), and aerated vigorously with shaking for 8 h in 4%
(w/v) glucose medium (to an A600 < 1.0) or for
20 h in ethanol or oleic acid media.
-Galactosidase activities were
assayed in soluble protein extracts prepared by breaking cells with
glass beads (27) and are expressed as nmol of
O-nitrophenyl-
-D-galactopyranoside
hydrolyzed /min
1/mg of protein. Catalase
measurements were performed as described (28). Acyl-CoA oxidase
activity was measured as the production of
trans-2-decenoyl-CoA from the substrate
n-decanoyl-CoA (Sigma). The rate of
trans-2-decenoyl-CoA generation was monitored
spectrophotometrically using 2-enoyl-CoA hydratase and
L-3-hydroxyacyl-CoA dehydrogenase as described previously
for the
3-
2-enoyl-CoA isomerase assay
(29).
![]()
RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
119 (TTCCATN30TCGGAG,
nucleotides in bold diverge from the palindrome consensus) with the 3'
half-site situated within the PEX11 ORE. A second potential
element in the PEX11 promoter, occurring as a tandem array
of two half-sites (CTCCAAN18CTCCAT), can be
found relatively close to the ATG start site at position
42.
mutant cells as
well as from control cells lacking either Pip2p, the specific activator
of ORE-regulated genes (8), or both Pip2p and Adr1p. The results showed
that the adr1
deletion caused a complete loss of
induction of both POX1 and PEX11 in cells grown
on oleic acid (Fig. 1A). This
defect was similar to that caused by the pip2
deletion.
The Northern blot results were validated using probes representing the
genes POT1/FOX3 and CTA1, which are subordinate
to varying extents to both Pip2p-Oaf1p and Adr1p (8, 9, 13, 14, 21,
35). ACT1 represented a control gene, the regulation of
which is independent of either transcription factor (Fig.
1A). The data indicated that Adr1p was probably important
for POX1 and PEX11 transcription.

View larger version (37K):
[in a new window]
Fig. 1.
Adr1p is critical for Pox1p and Pex11p
expression in cells grown on oleic acid medium. A, the
effect of disrupting ADR1 on POX1 and
PEX11 transcription. Logarithmic cultures of wild-type and
mutant strains were inoculated in media supplemented with the indicated
carbon sources and grown for 16 h. RNA extracted from these
strains was immobilized on a filter that was probed with labeled
DNA fragments containing the genes indicated. The strains used were
MF14, MF14adr1
, MF14pip2
, and
MF14adr1
pip2
. B,
immunoblotting using soluble protein extracts from cells grown in
the media indicated. The strains used were BJ1991 wild type,
BJ1991adr1
, and
BJ1991pip2
oaf1
.
, or pip2
oaf1
cells. The results demonstrated that under oleic acid-medium
conditions, Adr1p was essential for obtaining induced levels of Pox1p
and Pex11p, i.e. for increasing the amount of protein beyond
the levels already seen on the ethanol medium (Fig.
1B). This resembled the situation with cells lacking
Pip2p-Oaf1p (Fig. 1B). In comparison, Cta1p and particularly
Pot1p/Fox3p were less stringently regulated by Adr1p. Pgk1p served as
an internal control for equal loading of protein (Fig. 1B).
The dependence of Pox1p expression on Adr1p was underscored by assaying
for acyl-CoA oxidase activity in soluble protein extracts from oleic
acid-grown cells. The results showed that although oxidase activity
measured in the wild-type extracts reached 0.17 ± 0.04 (mean ± S.D., n = 3) nmol × min
1/mg of
protein, oxidase activity in extracts obtained from adr1
, pip2
oaf1
, or pox1
mutant
cells was below the detection limit of 0.02 nmol × min
1/mg of protein. Hence, the induced expression of
Pox1p and Pex11p under oleic acid medium conditions strictly depended
on Adr1p (in addition to Pip2p-Oaf1p), arguing in favor of a blockage
in both
-oxidation and peroxisome proliferation in
adr1
mutant cells.
oaf1
cells (Fig. 2D,
lanes 2 and 3). The addition of excess
POT1/FOX3 ORE (self-competitor DNA) caused this signal to
disappear (lane 4). Similarly, excessive amounts of either
POX1 ORE or UAS1POX1 were also able to
compete for the Pip2p-Oaf1p complex (lanes 7 and
8). As anticipated, this Pip2p-Oaf1p complex could also be
competed by adding excess SPS19 ORE but not
UAS1SPS19 (lanes 5 and 6).

View larger version (47K):
[in a new window]
Fig. 2.
Competition EMSA of POX1
promoter fragments showing interaction with Pip2p-Oaf1p and
Adr1p. A, diagram of the PEX11 promoter
section covering the UAS1-like element and the ORE. The terminal 3'-CCG
tripeptide is 112 nucleotides 5' of the ATG start site. B,
the overlap between the analogous two elements in the SPS19
promoter. The ATG start site occurs 127 nucleotides 3' of the sequence
depicted. C, the POX1 promoter fragment
containing UAS1POX1 and POX1 ORE. The terminal
3' nucleotide is situated 245 nucleotides 5' of the ATG start site.
D, EMSA using POT1/FOX3 ORE or
UAS1CTA1. Labeled DNA containing POT1/FOX3 ORE
or UAS1CTA1 was mixed with soluble protein extracts from
wild-type, adr1
, or pip2
oaf1
yeast cells or E. coli cells producing recombinant
Adr1p-LacZ as indicated, and free and bound DNA fragments were resolved
on a 5% (w/v) polyacrylamide gel. A 25-fold excess of unlabeled
double-stranded oligonucleotides was used for competition. The
arrows with asterisks indicate unidentified
complexes.

View larger version (13K):
[in a new window]
Fig. 3.
The arrangement of ORE and UAS1 in the
CTA1 promoter. A, diagram of the
CTA1 promoter fragment containing UAS1CTA1 and
CTA1 ORE. The terminal 3' nucleotide is situated 155 nucleotides 5' of the ATG start site. The bracket above the
CTA1 sequence represents the minimal element capable of
binding Adr1p. The lines below the sequence delineate
half-sites also occurring in the ADH2 sequence below.
B, the analogous UAS1 element in the ADH2
promoter. The ATG start site occurs 268 nucleotides 3' of the
sequence depicted. The bracket above the ADH2
sequence designates the region protected against DNase I digestion by
Adr1p. C, CTA1 promoter fragments (aligned with
the nucleotide sequence in A) used to confer transcriptional
activation on a basal CYC1-lacZ reporter gene.
-galactosidase and catalase
activities. The results demonstrated that wild-type cells expressed the
pMF14 reporter gene (containing both UAS1 and ORE) to at least a
4-fold greater extent than reporter genes consisting of either UAS1
(pMF17) or ORE (pMF22) alone (Table I). Oleic
acid-dependent activation of pMF14 relied on both Adr1p and
Pip2p, because a mutation of either gene reduced the levels of
-galactosidase activities to less than a fifth of the levels reached
in the wild-type strain. This reduction appeared to be exacerbated in
the adr1
pip2
double mutant. Catalase
activities measured in the same extracts substantiated the effect of
both the adr1
and pip2
mutations on the
expression of native CTA1 on oleic acid. Expression of the
UAS1CTA1-driven reporter (pMF17) was effectively abolished
in the adr1
mutant compared with the wild type, but also
in the pip2
mutant only a residual activity was
maintained. A similar situation was observed using the CTA1 ORE-containing reporter (pMF22) in that its expression was very low in
the pip2
mutant and only partially retained in the
adr1
mutant (Table I).
The effect of adr1
and pip2
deletions on the expression of
reporter genes based on CYC1-lacZ or on native CTA1 under ethanol or
oleic acid medium conditions
![]()
DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
-oxidation would be perturbed in adr1
mutant cells. This uncertainty was highlighted by the detection of relatively large
amounts of Pot1p/Fox3p in adr1
cells compared with cells devoid of Pip2p-Oaf1p (Fig. 1A). However, unlike the
situation with Pot1p/Fox3p, Adr1p was shown here to regulate Pox1p
expression very tightly. This strict dependence of the
-oxidation
spiral on Adr1p explains why adr1
mutants fail to degrade
oleic acid.
42) could also represent a functional
Adr1p element cannot be ruled out entirely, because at least in the
case of the GUT1 gene, such linearly arranged half-site
pairs have been shown previously to bind Adr1p (36, 41).
-oxidation. A significant reduction (5-fold) in peroxisome abundance
is also observed in human cell lines lacking peroxisomal acyl-CoA
oxidase (3). By extrapolating this situation to yeast
adr1
cells defective in peroxisomal acyl-CoA oxidase
(Pox1p) activity, the peroxisome proliferation phenotype of
adr1
cells might also turn out to be secondary to blocked
-oxidation (4). However, unlike the enlarged peroxisomes observed in
pox1
or pex11
cells, the few peroxisomes
seen in adr1
and pip2
mutant cells are
unusually small. We propose that the reason for the small peroxisomes
in these latter two mutant strains is because they contain less matrix
enzymes and membrane proteins compared with wild-type peroxisomes,
because of an absence of bulk transcription mediated by Adr1p and
Pip2p-Oaf1p.
mutant or the UAS1 reporter
(pMF17) in the pip2
mutant was less compared with that in
the wild-type strain. It is attractive to postulate that for efficient
expression of certain oleic acid-regulated genes, an enhanceosome-like
(42) transient complex might be formed in vivo between the
oleic acid-specific Pip2p-Oaf1p transcription factor and the more
general sensor of less-favored carbon sources, Adr1p.
124
(CTCCGGAGN3CTCCAA). In addition, the
OAF1 promoter was also found to contain a potential UAS1
(CTCCAGN28CTGGGG) at position
392. Adr1p might turn out
to influence the transcription of PIP2 and/or
OAF1, thereby adding another layer of (indirect) control
over genes subordinate to Pip2p-Oaf1p. Further work is required to
determine whether in this way Adr1p heads the transcriptional hierarchy
leading to oleic acid induction and peroxisome proliferation.
| |
FOOTNOTES |
|---|
* This work was supported by the Fonds zur Förderung der wissenschaftlichen Forschung (Vienna, Austria) Grants P12061-MOB (to H. R. and B. H.) and P12118-MOB (to A. H.) and grants from the Academy of Finland and the Sigrid Jusélius foundation (to J. K. H.).The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
§ To whom correspondence should be addressed: Tel.: 43-1-4277-52804; Fax: 43-1-4277-9528; E-mail: AG@abc.univie.ac.at.
** Supported by European Molecular Biology Organization long-term fellowship ALTF255-2000.
Published, JBC Papers in Press, June 28, 2001, DOI 10.1074/jbc.M105989200
| |
ABBREVIATIONS |
|---|
The abbreviations used are: ORE, oleate response element; UAS1, upstream activation sequence type 1; EMSA, electrophoretic mobility shift assay.
| |
REFERENCES |
|---|
|
|
|---|
| 1. | Moser, H. W. (1991) Clin. Biochem. 24, 343-351 |
| 2. | Lazarow, P. B. (1995) J. Neuropathol. Exp. Neurol. 54, 720-725 |
| 3. | Chang, C.-C., South, S., Warren, D., Jones, J., Moser, A. B., Moser, H. W., and Gould, S. J. (1999) J. Cell Sci. 112, 1579-1590 |
| 4. | Van Roermund, C. W., Tabak, H. F., Van Den Berg, M., Wanders, R. J., and Hettema, E. H. (2000) J. Cell Biol. 150, 489-498 |
| 5. | Simon, M., Adam, G., Rapatz, W., Spevak, W., and Ruis, H. (1991) Mol. Cell. Biol. 11, 699-704 |
| 6. | Kunau, W.-H., Dommes, V., and Schulz, H. (1995) Prog. Lipid Res. 34, 267-342 |
| 7. | Veenhuis, M., Mateblowski, M., Kunau, W.-H., and Harder, W. (1987) Yeast 3, 77-84 |
| 8. | Rottensteiner, H., Kal, A. J., Filipits, M., Binder, M., Hamilton, B., Tabak, H. F., and Ruis, H. (1996) EMBO J. 15, 2924-2934 |
| 9. | Luo, Y., Karpichev, I. V., Kohanski, R. A., and Small, G. M. (1996) J. Biol. Chem. 271, 12068-12075 |
| 10. | Simon, M. M., Pavlik, P., Hartig, A., Binder, M., Ruis, H., Cook, W. J., Denis, C. L., and Schanz, B. (1995) Mol. Gen. Genet. 249, 289-296 |
| 11. | Ciriacy, M. (1975) Mol. Gen. Genet. 138, 157-164 |
| 12. | Cheng, C., Kacherovsky, N., Dombek, K. M., Camier, S., Thukral, S. K., Rhim, E., and Young, E. T. (1994) Mol. Cell. Biol. 14, 3842-3852 |
| 13. | Simon, M., Binder, M., Adam, G., Hartig, A., and Ruis, H. (1992) Yeast 8, 303-309 |
| 14. | Igual, J. C., and Navarro, B. (1996) Mol. Gen. Genet. 252, 446-455 |
| 15. | Gurvitz, A., Rottensteiner, H., Kilpeläinen, S. H., Hartig, A., Hiltunen, J. K., Binder, M., Dawes, I. W., and Hamilton, B. (1997) J. Biol. Chem. 272, 22140-22147 |
| 16. | Gurvitz, A., Wabnegger, L., Rottensteiner, H., Dawes, I. W., Hartig, A., Ruis, H., and Hamilton, B. (2000) Mol. Cell Biol. Res. Commun. 4, 81-89 |
| 17. | Dmochowska, A., Dignard, D., Maleszka, R., and Thomas, D. Y. (1990) Gene (Amst.) 88, 247-252 |
| 18. | Erdmann, R., and Blobel, G. (1995) J. Cell Biol. 128, 509-523 |
| 19. | Marshall, P. A., Krimkevich, Y. I., Lark, R. H., Dyer, J. M., Veenhuis, M., and Goodman, J. M. (1995) J. Cell Biol. 129, 345-355 |
| 20. | Eisen, A., Taylor, W. E., Blumberg, H., and Young, E. T. (1988) Mol. Cell. Biol. 8, 4552-4556 |
| 21. | Filipits, M., Simon, M. M., Rapatz, W., Hamilton, B., and Ruis, H. (1993) Gene (Amst.) 132, 49-55 |
| 22. | Rottensteiner, H., Kal, A. J., Hamilton, B., Ruis, H., and Tabak, H. F. (1997) Eur. J. Biochem. 247, 776-783 |
| 23. | Gurvitz, A., Rottensteiner, H., Hiltunen, J. K., Binder, M., Dawes, I. W., Ruis, H., and Hamilton, B. (1997) Mol. Microbiol. 26, 675-685 |
| 24. | Jones, E. W. (1977) Genetics 85, 23-33 |
| 25. | Yaffe, M. P., and Schatz, G. (1984) Proc. Natl. Acad. Sci. U. S. A. 81, 4819-4823 |
| 26. | Erdmann, R., and Kunau, W.-H. (1994) Yeast 10, 1173-1182 |
| 27. | Miller, J. H. (1972) Experiments in Molecular Genetics , pp. 352-355, Cold Spring Harbor Laboratory, Cold Spring Harbor, New York |
| 28. | Beers, R. F., and Sizer, I. W. (1952) J. Biol. Chem. 195, 133-140 |
| 29. | Palosaari, P. M., Kilponen, J. M., Sormunen, R. T., Hassinen, I. E., and Hiltunen, J. K. (1990) J. Biol. Chem. 265, 3347-3353 |
| 30. | Sambrook, J., Fritsch, E. F., and Maniatis, T. (1989) Molecular Cloning: A Laboratory Manual , 2nd Ed. , Cold Spring Harbor Laboratory, Cold Spring Harbor, New York |
| 31. | Richter, K., Ammerer, G., Hartter, E., and Ruis, H. (1980) J. Biol. Chem. 255, 8019-8022 |
| 32. | Bradford, M. M. (1976) Anal. Biochem. 72, 248-254 |
| 33. | Laemmli, U. K. (1970) Nature 227, 680-685 |
| 34. | Gurvitz, A., Hamilton, B., Hartig, A., Ruis, H., Dawes, I. W., and Rottensteiner, H. (1999) Mol. Gen. Genet. 262, 481-492 |
| 35. | Einerhand, A. W., Kos, W. T., Distel, B., and Tabak, H. F. (1993) Eur. J. Biochem. 214, 323-331 |
| 36. | Grauslund, M., Lopes, J. M., and Rønnow, B. (1999) Nucleic Acids Res. 27, 4391-4398 |
| 37. | Baumgartner, U., Hamilton, B., Piskacek, M., Ruis, H., and Rottensteiner, H. (1999) J. Biol. Chem. 274, 22208-22216 |
| 38. | Hiltunen, J. K., Wenzel, B., Beyer, A., Erdmann, R., Fosså, A., and Kunau, W.-H. (1992) J. Biol. Chem. 267, 6646-6653 |
| 39. | Igual, J. C., Matallana, E., Gonzalez-Bosch, C., Franco, L., and Perez-Ortin, J. E. (1991) Yeast 7, 379-389 |
| 40. | Einerhand, A. W., Voorn-Brouwer, T. M., Erdmann, R., Kunau, W.-H., and Tabak, H. F. (1991) Eur. J. Biochem. 200, 113-122 |
| 41. | Pavlik, P., Simon, M., Schuster, T., and Ruis, H. (1993) Curr. Genet. 24, 21-25 |
| 42. | Merika, M., and Thanos, D. (2001) Curr. Opin. Genet. Dev. 11, 205-208 |
This article has been cited by other articles:
![]() |
I. V. Karpichev, J. M. Durand-Heredia, Y. Luo, and G. M. Small Binding Characteristics and Regulatory Mechanisms of the Transcription Factors Controlling Oleate-responsive Genes in Saccharomyces cerevisiae J. Biol. Chem., April 18, 2008; 283(16): 10264 - 10275. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Lockshon, L. E. Surface, E. O. Kerr, M. Kaeberlein, and B. K. Kennedy The Sensitivity of Yeast Mutants to Oleic Acid Implicates the Peroxisome and Other Processes in Membrane Function Genetics, January 1, 2007; 175(1): 77 - 91. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Orth, S. Reumann, X. Zhang, J. Fan, D. Wenzel, S. Quan, and J. Hu The PEROXIN11 Protein Family Controls Peroxisome Proliferation in Arabidopsis PLANT CELL, January 1, 2007; 19(1): 333 - 350. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. Hynes, S. L. Murray, A. Duncan, G. S. Khew, and M. A. Davis Regulatory Genes Controlling Fatty Acid Catabolism and Peroxisomal Functions in the Filamentous Fungus Aspergillus nidulans Eukaryot. Cell, May 1, 2006; 5(5): 794 - 805. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. P. Lin-Cereghino, L. Godfrey, B. J. de la Cruz, S. Johnson, S. Khuongsathiene, I. Tolstorukov, M. Yan, J. Lin-Cereghino, M. Veenhuis, S. Subramani, et al. Mxr1p, a Key Regulator of the Methanol Utilization Pathway and Peroxisomal Genes in Pichia pastoris Mol. Cell. Biol., February 1, 2006; 26(3): 883 - 897. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Wu, N. Zhang, A. Hayes, K. Panoutsopoulou, and S. G. Oliver Global analysis of nutrient control of gene expression in Saccharomyces cerevisiae during growth and starvation PNAS, March 2, 2004; 101(9): 3148 - 3153. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Rottensteiner, L. Wabnegger, R. Erdmann, B. Hamilton, H. Ruis, A. Hartig, and A. Gurvitz Saccharomyces cerevisiae PIP2 Mediating Oleic Acid Induction and Peroxisome Proliferation Is Regulated by Adr1p and Pip2p-Oaf1p J. Biol. Chem., July 18, 2003; 278(30): 27605 - 27611. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. T. Young, K. M. Dombek, C. Tachibana, and T. Ideker Multiple Pathways Are Co-regulated by the Protein Kinase Snf1 and the Transcription Factors Adr1 and Cat8 J. Biol. Chem., July 3, 2003; 278(28): 26146 - 26158. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Li and S. J. Gould The Dynamin-like GTPase DLP1 Is Essential for Peroxisome Division and Is Recruited to Peroxisomes in Part by PEX11 J. Biol. Chem., May 2, 2003; 278(19): 17012 - 17020. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Morgan, D. Conklin, A. J. Pawson, R. Sellar, T. R. Ott, and R. P. Millar A Transcriptionally Active Human Type II Gonadotropin-Releasing Hormone Receptor Gene Homolog Overlaps Two Genes in the Antisense Orientation on Chromosome 1q.12 Endocrinology, February 1, 2003; 144(2): 423 - 436. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. T. Young, N. Kacherovsky, and K. Van Riper Snf1 Protein Kinase Regulates Adr1 Binding to Chromatin but Not Transcription Activation J. Biol. Chem., October 4, 2002; 277(41): 38095 - 38103. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. G. Koerkamp, M. Rep, H. J. Bussemaker, G. P.M.A. Hardy, A. Mul, K. Piekarska, C. A.-K. Szigyarto, J. M. T. de Mattos, and H. F. Tabak Dissection of Transient Oxidative Stress Response in Saccharomyces cerevisiae by Using DNA Microarrays Mol. Biol. Cell, August 1, 2002; 13(8): 2783 - 2794. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |